NTLA | | Intellia Therapeutics, Inc. | Bell Graeme | EVP, Chief Financial Officer | Mar 28, 2018 | Option Exercise | $13.48 | 8,000 | 107,840 | 21,400 | Mar 30, 2018, 10:20 AM |
NTLA | | Intellia Therapeutics, Inc. | Bell Graeme | EVP, Chief Financial Officer | Nov 03, 2017 | Option Exercise | $22.04 | 5,000 | 110,217 | 13,400 | Nov 03, 2017, 11:54 AM |
NTLA | | Intellia Therapeutics, Inc. | Bell Graeme | EVP, Chief Financial Officer | Jun 02, 2017 | Option Exercise | $12.37 | 8,400 | 103,938 | 8,400 | Jun 05, 2017, 07:59 AM |
ANAC | | Anacor Pharmaceuticals, Inc. | Bell Graeme | Executive VP and CFO | Jun 24, 2016 | Option Exercise | $99.25 | 10,488 | 1,040,934 | 0 | Jun 24, 2016, 02:44 PM |
ANAC | | Anacor Pharmaceuticals, Inc. | Bell Graeme | Executive VP and CFO | Jun 01, 2016 | Sale | $99.28 | 751 | 74,559 | 10,255 | Jun 03, 2016, 09:00 PM |